News

AKF announces sponsorship from Novartis Pharmaceuticals Corporation for education and awareness campaigns for two rare kidney diseases: complement 3 glomerulopa...

AKF will present its poster "Barriers to genetic testing for determining cause of kidney disease among healthcare providers" at the American Society o...

AKF is excited to announce the formation of the UCKD Coalition, comprising 15 organizations and individuals aligned in their efforts to support policies and act...

AKF is excited to announce that GSK has joined the 2022 class in its Corporate Membership Program as a Champion-level member, helping AKF fulfill its mission to...

As a part of its Unknown Causes of Kidney Disease (UCKD) Project, AKF surveyed health care providers to understand opportunities and barriers in diagnosing chro...

AKF is pleased to announce that Vertex Pharmaceuticals Inc. is providing support for its education and awareness campaign about the apolipoprotein L1 (APOL1) ge...

New resources seek to create a supportive environment for women of color, who are disproportionally diagnosed with lupus nephritis